Entrada Therapeutics
TRDA
TRDA
48 hedge funds and large institutions have $243M invested in Entrada Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
44% less capital invested
Capital invested by funds: $434M → $243M (-$191M)
Holders
48
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.55M | |
| 2 | +$4.45M | |
| 3 | +$1.63M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$658K |
| 5 |
Walleye Capital
New York
|
+$419K |
Top Sellers
| 1 | -$5.35M | |
| 2 | -$4.37M | |
| 3 | -$796K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$416K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$190K |